ArticleOncotarget2016

Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.

Tara Williamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.